21 May 2018 | News
In her role as Chairman of the Board, Zaderej will lead efforts in developing and implementing the Company's strategic vision.
Singapore – AxoGen, a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced that its Board of Directors has elected Karen Zaderej as Chairman of the Board in addition to her current role as President and Chief Executive Officer (CEO), effective immediately. Zaderej succeeds Jamie M. Grooms, who will remain a Director of the Board.
In her role as Chairman of the Board, Zaderej will lead efforts in developing and implementing the Company's strategic vision. AxoGen is creating a platform for nerve repair with innovative solutions and expanding applications to improve the quality of life for patients with peripheral nerve damage.
“I am deeply honored to be named Chairman of AxoGen,” said Zaderej. “We are building a culture that attracts, inspires, motivates, and develops individuals and teams to achieve excellence by embracing our values. We are just getting started, and we have a tremendous opportunity to improve the quality of life and offer hope for patients with debilitating nerve damage.”
Further, the AxoGen Board of Directors also elected Amy Wendell to the newly created role of Lead Director. The Lead Director facilitates the functioning of the Board of Directors independently of management of the Company and provides independent leadership to the Board of Directors.